Ocular Melanoma Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
IOVA | B | Iovance Biotherapeutics, Inc. | 7.18 | |
DCTH | B | Delcath Systems, Inc. | -3.58 |
Related Industries: Biotechnology Medical Devices
Related Stock Lists:
Medicine
Melanoma
Oncology
Adoptive Cell Transfer
Antineoplastic Drugs
Biopharmaceutical
Breast And Lung Cancer
Cancer
Cancer Cell
Cancer Immunotherapy
Cancer Immunotherapy Product
Cancer Treatment
Carcinoma
Cell Therapy
Checkpoint Inhibitor
Chemotherapy
Chloride
Cholangiocarcinoma
Clinical Development
Clinical Medicine
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IDNA | C | iShares Genomics Immunology and Healthcare ETF | 2.72 | |
WDNA | D | WisdomTree BioRevolution Fund | 2.13 | |
BBP | A | BioShares Biotechnology Products Fund | 1.86 | |
CNCR | F | Loncar Cancer Immunotherapy ETF | 1.35 | |
LABD | D | Direxion Daily S&P Biotech Bear 3X Shares | 1.07 |
Compare ETFs
Related Industries:
Biotechnology
Medical Devices
Related Stock Lists:
Medicine
Melanoma
Oncology
Adoptive Cell Transfer
Antineoplastic Drugs
Biopharmaceutical
Breast And Lung Cancer
Cancer
Cancer Cell
Cancer Immunotherapy
Cancer Immunotherapy Product
Cancer Treatment
Carcinoma
Cell Therapy
Checkpoint Inhibitor
Chemotherapy
Chloride
Cholangiocarcinoma
Clinical Development
Clinical Medicine
- Ocular Melanoma
Uveal melanoma is a cancer (melanoma) of the eye involving the iris, ciliary body, or choroid (collectively referred to as the uvea). Tumors arise from the pigment cells (melanocytes) that reside within the uvea giving color to the eye. These melanocytes are distinct from the retinal pigment epithelium cells underlying the retina that do not form melanomas. When eye melanoma is spread to distant parts of the body, the 5-year survival rate is about 15%.
Popular Now
Recent Comments
- Cos3 on Adding float as advanced filter criteria?
- FriendlyOyster657 on BOOT
- TraderMike on Filtering by News?
- Dr_Duru on Filtering by News?
- TraderMike on Filtering by News?
From the Blog
Featured Articles